A message from Wuhan residents to countries that scrutinized the city s lockdown, one year on
Chen Qingqing co-leads the Global Times China desk. She covers diplomacy, Hong Kong affairs and Chinese tech firms.
Chen Qingqing in Beijing, Yang Cheng in Wuhan Published: Jan 22, 2021 08:29 PM Updated: Jan 22, 2021 10:03 PM
Editor s note:
A year ago, Wuhan, where the coronavirus was first reported in China, made a decision that has little parallel in modern society: to lock down the city of 11 million. During the 76-day lockdown, the city struggled to save lives and contain the virus, while maintaining the daily lives of ordinary people, a strategy that Chinese top epidemiologists said to suffocate the virus within Wuhan. The city was therefore dubbed a heroic city, whose sacrifice paved the way for the quick recovery of the country. When the city returned to bustling normal life in April, and Western countries, one by one, faced a more severe onslaught of the coronavirus, many W
China’s state-run
Global Times on Wednesday put the happiest possible spin on a dismaying Brazilian study that showed China’s Sinovac vaccine candidate for the Chinese coronavirus is only 50 percent effective.
Even though the results were far below the 80 percent effectiveness originally claimed and that, in turn, was far below the estimates for vaccines like the one made by Pfizer the
Global Times declared it was “good enough.”
Sao Paulo-based Instituto Butantan, the research institute developing the Sinovac product for distribution in Brazil, announced last week that clinical tests showed it to be 78 percent effective overall. On Tuesday, the institute revealed at a press conference that late-stage trials involving over 12,000 volunteers showed it was only 50.38 percent effective overall, although the Brazilian researchers said it was much more effective at treating “severe” cases of Chinese coronavirus than mild infections.
Brazil official: China vaccine capable of preventing disease, death chinadaily.com.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chinadaily.com.cn Daily Mail and Mail on Sunday newspapers.
BEIJING (Global Times): Sinovac's Covid-19 vaccine is 100 per cent effective in preventing severe and moderate infections, 77.96 per cent effective in preventing mild cases, and has an overall efficacy of 50.4 per cent in Brazil's final-stage trials.
China’s CoronaVac COVID-19 vaccine produced by Sinovac has been proven safe and effective after phase III trials conducted in several countries, boosting public confidence over its global rollout as Indonesian President Joko Widodo received his first shot of the CoronaVac vaccine on Wednesday.